Vancouver, British ColumbiaAnd 25 April 2022 / cnw / – Vext Science, Inc. (“Vext” or “the Company”) (CSE: VEXT) (OTCQX: VEXTF) is a leading cannabis brand based in ArizonaLeveraging its core expertise in extraction, processing, farming and marketing to build a profitable multi-nation footprint, today announced that it will participate in the sixth annual Cannabis Conference at Canaccord Genuity in May 11 2022.
CEO of the company Eric Offenberger will present day Wednesday May 11 at 3 p.m. Eastern time Management will participate in one-to-one virtual meetings with investors throughout the event. The conference will be held via webcast and a link to the presentation is available hereAs well as on the company’s website.
For more details, visit Vext’s Investor’s website Or contact the IR team at Investors@vextscience.com.
About Vext Science, Inc.
Vext Science, Inc. is a US-based company of Cannabis THC and Hemp cannabinoid products that manufactures THC cartridges, concentrates, foods and accessories under the Vapen™ brand and Hemp-based products under the Pure Touch Botanicals brand as well as the Vapen CBD brand. depends on Arizona, Vext Science, Inc. It has one of the leading brands of concentrated, edible THC and distillate sold at most of the state’s 100+ dispensaries. Herbal Wellness Center is one of Arizona Leading dispensaries and we carry out all aspects of cultivation, extraction, food infusion and manufacturing that guarantee a product of the highest quality and purity. Product quality and purity are fundamental to our marketing strategy. Vext Science, Inc. Carrying out the growth of its business by leveraging expertise and experience in extraction, product manufacturing and marketing to expand into the United States through joint venture partnerships to share revenue and profits. For more information visit our website at www.VextScience.com Or contact us at LinkedIn And Twitter.
For more details about the Vapen brand:
Vapen website: VapenBrands.com
Instagram: Tweet embed
Facebook: Tweet embed
COVID-19 risk factor
Vext may be affected by business interruptions resulting from epidemics and public health emergencies, including those related to COVID-19. An outbreak of an infectious disease, pandemic, or similar threat to public health, such as the recent outbreak of COVID-19, or fear of any of the above, may negatively impact Vext by causing operational, manufacturing, supply chain, and project delays and disruptions to development, labor shortages, and disruption Travel, shipping and closing (including as a result of government regulation and prohibition measures). It is not known if and how Vext may be affected if this pandemic continues for an extended period of time, including as a result of waiving regulatory requirements or implementing emergency regulations to which Vext is subject. Although Vext has been deemed necessary and/or allowed to continue operating its facilities in the states in which it operates during the COVID-19 pandemic, there is no guarantee that the Company’s operations will continue to be deemed necessary and/or will continue to be permitted to operate. Vext may incur expenses or delays in connection with such events outside its control, which could have a material adverse effect on its business, operating results, financial condition and trading price of the Company’s common stock.
forward-looking statements
Statements in this press release that are forward-looking statements are subject to various risks and uncertainties regarding specific factors disclosed here and elsewhere in Vext’s periodic filings with Canadian securities regulators. When used in this news release, words such as “will, can, plan, estimate, anticipate, intend, possibly, likely, believe, should,” and similar expressions are forward-looking statements.
Forward-looking statements may include, but are not limited to, statements regarding COVID-19, future developments, and Vext’s business and operations.
Although Vext attempts to identify significant factors that could cause actual results, performance or achievements to differ materially from those expressed in the forward-looking statements, there could be other factors that could cause results, performance or achievements not to be expected as expected or estimated. or means, but is not limited to: reliance on obtaining regulatory approvals; engage in activities that are currently illegal under US federal laws; change in laws relying on management; additional financing requirements; competition; Market growth and state adoption have been hampered by inconsistent public opinion and perception of marijuana use for medical purposes, adult abuse, and; organizational or political change.
There can be no guarantee that this information will prove to be accurate or that management’s expectations or estimates of future developments, conditions or results will be achieved. Because of these risks and uncertainties, the results or events anticipated in these forward-looking statements could differ materially from the actual results or events.
Accordingly, readers should not place undue reliance on forward-looking statements. The forward-looking statements contained in this press release are made as of the date of this release. Vext disclaims any intention or obligation to update or review this information, except as required by applicable law, and Vext has no responsibility for disclosure with respect to any other company mentioned herein.
The Canadian Stock Exchange has not reviewed, approved, or rejected the content of this press release.
Eric Offenberger
chief executive officer
844-211-3725
SOURCE VEXT Science, Inc.
*************
Are you looking for medical marijuana growing guides and books about cannabis? Then you should not miss our online bookstore with hundreds of books about marijuana.
********
